QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ORKA

QT80Oruka Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
72.34
+1.46+2.06%
OverviewShort InterestFilings
ORKAQT80Oruka Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
72.34+2.06%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own11.98%
Shs Outstand60.31M
Perf Week5.65%
Market Cap2.65BForward P/E-EPS next Y-2.49Insider Trans0.08%Shs Float-Perf Month25.81%
Enterprise Value2.61BPEG-EPS next Q-0.49Inst Own-Short Float-Perf Quarter86.35%
Income-78839015.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y149.97%
Sales-P/B8.03EPS next Y-18.03%ROA-23.04%Short Interest-Perf YTD138.67%
Book/sh8.07P/C-EPS next 5Y-ROE-25.99%52W High91.01 -20.51%Perf Year504.34%
Cash/sh6.45P/FCF-EPS past 3/5Y-ROIC-27.31%52W Low10.77 571.68%Perf 3Y-
Dividend Est.-EV/EBITDA-22.44Sales past 3/5Y-Gross Margin0.00%Volatility3.50% 4.00%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM61.12%Oper. Margin0.00%ATR (14)4.10Perf 10Y-
Dividend Ex-DateAug 29, 2024Quick Ratio23.76Sales Y/Y TTM-Profit Margin0.00%RSI (14)64.01Recom2.00
Dividend Gr. 3/5Y-Current Ratio23.76EPS Q/Q-20.00%SMA2015.20%Beta1.49Target Price149.50
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA5011.89%Rel Volume1.75Prev Close70.88
Employees28LT Debt/Eq0.00EarningsAug 10SMA20086.94%Avg Volume1.71MPrice72.34
IPO DateAug 08, 1997Option/ShortYes / YesEPS/Sales Surpr.12.24% -Net Debt/EBITDA0.41Volume2,986,482Change2.06%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-02-26ReiteratedPiper Sandler$75 → $180
Apr-30-26ReiteratedLeerink PartnersOutperform$109 → $120
Apr-29-26ReiteratedH.C. Wainwright$75 → $120
Apr-28-26ReiteratedUBSBuy$50 → $100
Apr-27-26ReiteratedWedbushOutperform$85 → $165
Apr-27-26ReiteratedGuggenheimBuy$125 → $200
Apr-27-26ReiteratedBTIGBuy$73 → $151
Apr-15-26ReiteratedWedbushOutperform$45 → $85
Mar-13-26ReiteratedBTIGBuy$73
Jan-13-26ReiteratedWedbushOutperform$40 → $45
Latest News
Jun-10-26
Jun-10-2601:55PM
Wall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to TradeYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other21136
Research and Development101751
Other Operating Expense000
Operating Income-122-88-7
Interest Expense010
Unusual Expense
———
Non-Operating Income (Expense)-17-6-2
Net Income Before Taxes-105-84-5
Income Taxes
000
Consolidated Net Income-105-84-5
Net Income From Continuing Operations-105-84-5
Net Income-105-84-5
EPS (Recurring)-2.31-4.99-4.44
EPS (Basic, Before Extraordinaries)-2.31-4.99-4.44
EPS (Diluted)-2.31-4.99-4.44
EBITDA-105-82-5
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding461714
Market Capitalization1,394——
Operating Lease Expense
———
Insider Trading Volume
$78.57$69.52$60.46$51.41$42.36● Close Price0.00M1.89M3.78M5.66M7.55MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Goncalves JoanaChief Medical OfficerJun 15 '26Option Exercise7.3214,000102,480204,063Jun 15 12:00 AM
Goncalves JoanaChief Medical OfficerJun 15 '26Sale69.287,947550,60632,718Jun 15 12:00 AM
Klein Lawrence OttoChief Executive OfficerJun 15 '26Sale69.691,729120,494925,580Jun 15 12:00 AM
Sandler Laura LeeChief Operating OfficerJun 15 '26Sale69.6960041,814236,384Jun 15 12:00 AM
Quinlan Paul TGeneral CounselJun 15 '26Sale69.6973351,08331,034Jun 15 12:00 AM
Agarwal ArjunSenior Vice President, FinanceJun 15 '26Sale69.6939527,52816,899Jun 15 12:00 AM
Agarwal ArjunSenior Vice President, FinanceJun 12 '26Option Exercise15.8818,918300,350110,000Jun 15 12:00 AM
Agarwal ArjunSenior Vice President, FinanceJun 12 '26Sale69.729,459659,50817,294Jun 15 12:00 AM
Dambkowski CarlDirectorJun 12 '26Sale70.1112,583882,18238,743Jun 12 12:00 AM
Dambkowski CarlDirectorJun 11 '26Sale70.1322,4171,572,20151,326Jun 12 12:00 AM
Dambkowski CarlDirectorMay 21 '26Option Exercise7.95124,520989,610178,743May 22 12:00 AM
Dambkowski CarlDirectorMay 21 '26Sale58.97105,0006,191,36673,743May 22 12:00 AM
Agarwal ArjunSenior Vice President, FinanceMay 18 '26Sale59.0710,290607,80616,406May 18 12:00 AM
Agarwal ArjunSenior Vice President, FinanceMay 18 '26Option Exercise28.8015,666451,194118,000May 18 12:00 AM
Goncalves JoanaChief Medical OfficerMay 15 '26Option Exercise7.3214,000102,480207,563May 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR